Heated chemo during surgery may ease life for advanced ovarian cancer patients
NCT ID NCT03188432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving heated chemotherapy directly into the abdomen during surgery can improve quality of life for people with advanced ovarian, fallopian tube, or peritoneal cancer. Fifty participants received the treatment after standard chemotherapy. Researchers measured quality of life and abdominal discomfort using questionnaires. The goal was to see if this approach helps patients feel better after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Carboplatin (heated chemotherapy)
What this could lead to
If successful, this approach could improve quality of life for people with advanced ovarian cancer by reducing side effects and better targeting remaining cancer cells after surgery.
What could go wrong
This is a small, early-phase study with only 50 participants and no comparison group, so results may not apply broadly. Heated chemotherapy also carries risks like infection or organ damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IIIC FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States